Genomatica secures lead investor to bring equity investments to $90m

By Becky Bargh | 23-Oct-2018

Lead investors include Casdin Capital, Viking Global Investors and Ginkgo Bioworks

You need to be a subscriber to read this article.
Click here to find out more.

Chemical manufacturing company Genomatica has secured US$90m of equity investments following a drive to increase capital.

Participants include new lead investor

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like